Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates.

Literature DB >> 10857102

Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates.

B P Morgan¹.

Abstract

Mesh：

Year: 2000 PMID： 10857102 DOI： 10.1385/1-59259-056-X:61

Source DB: PubMed Journal: Methods Mol Biol ISSN： 1064-3745

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury.

Authors: Valeria Ramaglia; Ruud Wolterman; Maryla de Kok; Miriam Ann Vigar; Ineke Wagenaar-Bos; Rosalind Helen Mary King; Brian Paul Morgan; Frank Baas
Journal: Am J Pathol Date: 2008-03-18 Impact factor: 4.307

2. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.

Authors: Marieta M Ruseva; Tao Peng; Melissa A Lasaro; Keith Bouchard; Susan Liu-Chen; Fang Sun; Zhao-Xue Yu; Andre Marozsan; Yi Wang; Matthew C Pickering
Journal: J Am Soc Nephrol Date: 2015-06-05 Impact factor: 10.121

3. The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection.

Authors: Christopher D Romero; Tushar K Varma; Jason B Hobbs; Aimee Reyes; Brandon Driver; Edward R Sherwood
Journal: Infect Immun Date: 2011-06-06 Impact factor: 3.441

4. Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?

Authors: David Kavanagh; Isabel Y Pappworth; Holly Anderson; Christine M Hayes; Iain Moore; Eva-Maria Hunze; Karim Bennaceur; Pietro Roversi; Susan Lea; Lisa Strain; Roy Ward; Nick Plant; Corina Nailescu; Timothy H J Goodship; Kevin J Marchbank
Journal: Clin J Am Soc Nephrol Date: 2012-01-05 Impact factor: 8.237

10. Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism.

Authors: Erin Mehlhop; Anja Fuchs; Michael Engle; Michael S Diamond
Journal: Virology Date: 2009-09-09 Impact factor: 3.616

Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates.

1. Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury.

2. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.

3. The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection.

4. Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?

5. Complement-Mediated Neutralization of a Potent Neurotropic Human Pathogen, Chandipura Virus, Is Dependent on C1q.

6. An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.

7. Alterations in the complement cascade in post-traumatic stress disorder.

8. Two mutations of the C7 gene, c.1424G > A and c.281-1G > T, in two Korean families.

9. Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein.

10. Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism.